TOPFUND WHERE YOUR MONEY GROWS
Home / Stocks / Indo Us Biotech Ltd
INDOUS

Indo Us Biotech Ltd Share Price

Live price, chart and which mutual funds hold this stock

TopFund Score: 50/100 · Average See breakdown ↓
…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 25 Sep 2026

₹77.6

Change

-0.46 (-0.59%)

Open

₹79.9

Prev. Close

₹78.06

Day High

₹79.9

Day Low

₹77.25

Volume Analysis

Traded

2,473

Delivered

2,334

Delivery %

94.38%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (0)

No signal for this stock

Weaknesses (1)

  • •Promoter holding is falling

Opportunities (0)

No signal for this stock

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹81.9 ₹80.9 ₹79.25 ₹78.25 ₹76.6 ₹75.6 ₹73.95
Fibonacci ₹80.9 ₹79.89 ₹79.26 ₹78.25 ₹77.24 ₹76.61 ₹75.6
Camarilla ₹78.33 ₹78.09 ₹77.84 ₹78.25 ₹77.36 ₹77.11 ₹76.87

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

-35.6%

1 Week

-1.15%

1 Month

-4.09%

3 Months

-11.41%

6 Months

-23.74%

1 Year

-41.51%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹36.18

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

13.12%

Net margin 10.24% × asset turnover 0.89x × equity multiplier 1.44x

Company Overview

Sector

Fast Moving Consumer Goods

Market Cap

₹157 Cr

P/E (TTM)

30.9

ROE

16.9%

Book Value

₹21.0

Face Value

₹10.0

Source: Screener.in (Consolidated figures) — data as of 24 Sep 2026. Not investment advice.

TopFund Analysis

Indo Us Biotech Ltd lands in the middle of the pack on TopFund's composite fundamentals check within the Fast Moving Consumer Goods sector, at 50/100. The strongest factor is Financial Strength (98/100), while Momentum (9/100) is the weakest area to weigh before deciding. Notably: Promoter holding is falling.

TopFund Score — Fundamentals Quality

50/100 — Average

Data confidence: 74/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 27 Sep 2026 · How we calculate this →

Financial Strength

98

Valuation

44

Cash Flow

13

Corporate Governance

43

Momentum

9

Institutional Ownership

30

Business Quality

67

Risk & Volatility

57

Liquidity

50

From Screener.in

  • +Debtor days have improved from 191 to 152 days.
  • −Tax rate seems low
  • −Company has high debtors of 152 days.

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Announcement under Regulation 30 (LODR)-Newspaper Publication 06 Sep

Notice of 22nd AGM of the company to be held 30th September, 2026 through VC/OCAM published in Newspaper.

Reg. 34 (1) Annual Report. 5 Sep 05 Sep
Intimation Of Book Closure For The Purpose Of 22Nd AGM Pursuant To Regulation 42 Of SEBI (LODR) 05 Sep

22nd AGM on 30 Sep 2026; book closure 23-30 Sep; proposes 250 crore borrowing limit.

Shareholder Meeting- AGM On Sep 30, 2026 5 Sep 05 Sep

Source: BSE regulatory filings, via Screener.in.

Profit & Loss (Yearly)

  Mar 2020 Mar 2021 Mar 2022
Sales + 40 39 49
Expenses + 36 34 43
Operating Profit 4 5 7
OPM % 10.01% 13.58% 13.75%
Other Income + 0 0 0
Interest 1 1 1
Depreciation 0 0 0
Profit before tax 3 4 5
Tax % 11.54% -24.68% 4.71%
Net Profit + 3 5 5
EPS in Rs 2 3 3
Dividend Payout % 0.0% 0.0% 0.0%

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2020 Mar 2021 Mar 2022
Reserves 10 15 29
Borrowings + 9 12 13
Other Liabilities + 10 11 4
Total Liabilities 35 44 56
Fixed Assets + 1 2 6
CWIP 1 2 2
Investments 0 0 0
Other Assets + 32 39 48
Total Assets 35 44 56
Equity Capital 6 6 9

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2020 Mar 2021 Mar 2022
Cash from Operating Activity + -1 0 3
Cash from Investing Activity + -1 -2 -5
Cash from Financing Activity + 2 2 3
Net Cash Flow 0 0 0
CFO/OP -20 6 46
Free Cash Flow -1 -2 -1

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 70.17% → 68.29%
  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Public 29.83% 29.83% 29.83% 29.82% 29.83% 29.82% 29.83% 29.83% 29.83% 29.83% 31.53% 31.7%
Promoters 70.17% 70.17% 70.18% 70.18% 70.18% 70.18% 70.18% 70.18% 70.18% 70.18% 68.29% 68.29%
FII 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.18% 0.01%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Fast Moving Consumer Goods — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Indo Us Biotech Ltd (this stock) 157 30.9 3.72 16.9%
Dhunseri Tea & Ind. Ltd. 151 — 0.28 -2.33%
Mangalam Seeds Ltd. 142 10.2 1.69 9.72%
Comfort Intech Ltd. 185 — 1.07 -1.81%
B & A Ltd. 121 163.0 0.88 -2.85%
Waterbase Ltd. 194 — 1.37 -9.9%
Shreeoswal S And Che Ltd 120 9.8 2.35 15.2%

Which Mutual Funds Hold Indo Us Biotech Ltd?

Frequently Asked Questions about Indo Us Biotech Ltd

Community Sentiment

What are other investors saying about Indo Us Biotech Ltd?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.